Cargando…

Polymorphisms of HPC2/ELAC2 and SRD5A2 (5α-Reductase Type II) Genes in Prostate Cancer

Prostate cancer is the proliferation of malignant cells in the prostate gland. The HPC2/ELAC2 gene on chromosome 17p11.2 and SRD5A2 gene on chromosome 2p22–23 are predisposing genetic factors. We examined the relationship between Ser217Leu and Ala541Thr polymorphisms of the former gene, and Ala49Thr...

Descripción completa

Detalles Bibliográficos
Autores principales:	İzmirli, M, Arikan, B, Bayazit, Y, Alptekin, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Macedonian Science of Sciences and Arts 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776688/ https://www.ncbi.nlm.nih.gov/pubmed/24052700 http://dx.doi.org/10.2478/v10034-011-0015-2

Ejemplares similares

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

Evidence for an Association between the SRD5A2 (Type II Steroid 5α-Reductase) Locus and Prostate Cancer in Italian Patients
por: Margiotti, K., et al.
Publicado: (2000)

The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population
por: Choi, Se Young, et al.
Publicado: (2015)

Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency
por: Cheng, Tong, et al.
Publicado: (2019)

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
por: Mononen, N, et al.
Publicado: (2001)

Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
por: Marzuki, Nanis S., et al.
Publicado: (2019)

The Genotype-Phenotype Correlation in Human 5α-Reductase Type 2 Deficiency: Classified and Analyzed from a SRD5A2 Structural Perspective
por: Seo, Jieun, et al.
Publicado: (2023)

Genotype–Phenotype Correlation Analysis and Identification of a Novel SRD5A2 Mutation in Four Unrelated Chinese Patients with 5α-Reductase Deficiency
por: Gui, Ting, et al.
Publicado: (2022)

THU183 The Genotype-phenotype Correlation In Human 5α-reductase Type 2 Deficiency: Classified And Analysed From A SRD5A2 Structural Perspective
por: Kwon, Ahreum, et al.
Publicado: (2023)

Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels
por: Rył, Aleksandra, et al.
Publicado: (2017)

Try235Phe homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Turkish patient
por: Parlak, Mesut, et al.
Publicado: (2014)

ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case–control studies
por: Xu, B, et al.
Publicado: (2010)

Effects on Steroid 5-Alpha Reductase Gene Expression of Thai Rice Bran Extracts and Molecular Dynamics Study on SRD5A2
por: Khantham, Chiranan, et al.
Publicado: (2021)

Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism
por: Han, Yufei, et al.
Publicado: (2021)

Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in psoriasis in southern Turkey
por: Izmirli, Muzeyyen, et al.
Publicado: (2016)

46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene
por: Chávez, Bertha, et al.
Publicado: (2014)

Association between SRD5A2 rs523349 and rs9282858 Polymorphisms and Risk of Benign Prostatic Hyperplasia: A Meta-Analysis
por: Zeng, Xian-Tao, et al.
Publicado: (2017)

Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications
por: Fang, Cheng, et al.
Publicado: (2017)

Association of Some Polymorphisms in the VDR Gene, CYP17 Gene and SRD5A2 Gene and Prostate Cancer among Lebanese Men
por: El Ezzi, Asmahan A, et al.
Publicado: (2017)

Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency
por: Eren, Erdal, et al.
Publicado: (2016)

Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
por: Luo, Yunxiu, et al.
Publicado: (2021)

Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations
por: Paucar, Martin, et al.
Publicado: (2018)

ELAC2/RNaseZ-linked cardiac hypertrophy in Drosophila melanogaster
por: Migunova, Ekaterina, et al.
Publicado: (2021)

AB215. Variants in the SRD5A2 gene are associated with quality of semen
por: Zhao, Dan, et al.
Publicado: (2014)

A novel pathogenic variant of SRD5A2 in an Iranian psuedohermaphrodite male
por: Dalili, Setilla, et al.
Publicado: (2020)

The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2017)

Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)
por: Mai, Qicong, et al.
Publicado: (2020)

Computer aided screening of inhibitors to 5-α reductase type 2 for prostate cancer
por: Bhattacharjee, Biplab, et al.
Publicado: (2011)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
por: Lewis, Michael J, et al.
Publicado: (2004)

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
por: Schroeder, Cornelia, et al.
Publicado: (2019)

Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population
por: Hu, Xue, et al.
Publicado: (2018)

Prevalence of the Ser217Leu Variant of the ELAC2 Gene and Its Association with Prostate Cancer in Population of the Littoral Region of Cameroon
por: Djomkam, Alexandra Lindsey Zune, et al.
Publicado: (2019)

Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract
por: Katleba, Kimberley, et al.
Publicado: (2022)

ELAC2 Functions as a Key Gene in the Early Development of Placental Formation Based on WGCNA
por: Liang, Junyong, et al.
Publicado: (2023)

Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy
por: Wang, Zongwei, et al.
Publicado: (2020)

Adult phenotype and further phenotypic variability in SRD5A3-CDG
por: Kara, Bülent, et al.
Publicado: (2014)

Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
por: Liu, Zhanliang, et al.
Publicado: (2022)

Genetic polymorphisms of estrogen receptor alpha and catechol-O-methyltransferase genes in Turkish patients with familial prostate carcinoma
por: Pazarbasi, Ayfer, et al.
Publicado: (2013)

Molecular Characterization of Two Known SRD5A2 Gene Variants in Mexican Patients With Disorder of Sexual Development
por: María Guadalupe, Ortiz-López, et al.
Publicado: (2022)

5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis
por: Kapp, Friedrich G, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_arvihqv9g79pkan8ul48urngal